| Popis: |
Objectives: Among the various Covidien-19 vaccine, Sinovac vaccination program in Turkey is carried out by coronavac vaccine developed by Chinese firms. Our aim was to determine the early side effects of CoronaVac vaccine in Turkish healthcare professionals. Materials and methods: Volunteer healthcare personnel vaccinated with CoronaVac were evaluated four weeks after the first dose. Demographic, clinical characteristics, and post-vaccination side effects were recorded. Statistical analysis was performed with SPSS 15.0 software. Results: The study was conducted with 516 volunteers. The mean age was 34.53 ± 7.80 years, and the majority of the participants (58.1%) were women. The most common occupational nursing (34.8%) and smoking rate in the study was 27.1%. Approximately one third (31%) of the participants had a previous COVID-19 infection and antibody positivity (27.9%). The most common side effects were determined to be arm pain (55.8%) followed by headache (24.8%), fatigue (18.6%) and joint pain (7.8%). On the third day after vaccination, the diagnosis of COVID-19 was reported in one person. Four (0.8%) stated that they took a break from their daily routine due to syncope and one person due to COVID-19. Conclusion: In this study, no life-threatening side effects were reported in the early period after CoronaVac. Among the early side effects of CoronaVac vaccine in our study, the most common side effects were Arm soreness, Headache, Fatigue and Joint pain. We argue that it is important to use multi-layered and evidence-based strategies to raise the frequency of vaccination and to address the concerns and ownership of the vaccine in relation to the COVID-19 vaccine. In order to minimize widespread information pollution and hostility associated with vaccination, healthcare professionals should lead and strongly support vaccination programs. |
